Donor Lymphocyte Infusion: Clinical Trials

1 trial for Donor Lymphocyte Infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Donor Lymphocyte Infusion: new trials by email Literature Review of Donor Lymphocyte Infusion trials Research Report on Donor Lymphocyte Infusion

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Exercise, Isoproterenol, Placebo - Leukemia, Hematopoetic Stem Cell Transplantation
Early Phase 1RecruitingUniversity of Arizona2002018-01-242026-06-05

Narrower conditions

Leukemia (1)  ·  Lymphoma (1)  ·  Motor Activity (1)

Broader conditions

Behavior (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Bisoprolol (1)  ·  Carvedilol (1)  ·  Exercise (1)  ·  Isoproterenol (1)  ·  Nadolol (1)  ·  Roflumilast (1)  ·  Tablets (1)

Sponsors

University of Arizona (1)

Countries

United States (1)

Results publications

PMID 36189306, PMID 36719647, PMID 37077913, PMID 38592213, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554

NIH funding

R01CA277493 (1)